Related Experiment Video
Updated: Aug 11, 2026
08:08
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
Published on: July 8, 2011
Therapeutic potential of dendritic-based vaccines
1Immunotherapeutics Division, Northwest Biotherapeutics, Inc. 120 Northgate Plaza, Suite 219, Seattle, WA 98125, USA.
Expert Opinion on Investigational Drugs
|July 5, 2005
Summary
Dendritic cells (DCs) are key antigen-presenting cells that initiate and modulate immune responses. Research into DC-based therapeutics explores their potential in vaccines and treating various diseases.
Area of Science:
- Immunology
- Cell Biology
- Therapeutics
Background:
- Immune response initiation requires antigen processing and presentation.
- Dendritic cells (DCs) are highly efficient antigen-presenting cells crucial for immune regulation.
- DCs play a vital role in both initiating and suppressing immune responses, including tolerance induction.
Purpose of the Study:
- To review basic research on dendritic cell (DC)-based therapeutics.
- To discuss recent and ongoing clinical trials involving DC-based treatments.
Main Methods:
- Review of existing scientific literature on dendritic cell biology and applications.
- Analysis of data from clinical trials involving DC-based therapies.
Main Results:
- Dendritic cells (DCs) are potent initiators and modulators of immune responses.
- DCs are integral to the development of numerous vaccines and therapeutic strategies.
- Clinical trials are actively investigating the efficacy of DC-based treatments.
Conclusions:
- Dendritic cell research is advancing the development of novel vaccines and immunotherapies.
- DC-based therapeutics hold significant promise for treating a range of diseases.
- Ongoing clinical investigations are crucial for translating DC research into clinical practice.
More Related Videos
Related Concept Videos
01:51Vaccinations
Overview
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...